Efficacy

Study shows DHPS enzyme controls macrophage maturation across multiple organs

April 21, 2026

Tumor-associated macrophages (TAMs) within the tumor microenvironment (TME) exhibit significant metabolic dysregulation, which impairs their antitumor function. Specifically,…

HHealth

Cancer cells found to use ketones as alternate fuel for growth

April 15, 2026

The largest published prospective evaluation of off-label targeted cancer therapies has shown that more patients could benefit from…

SScience

ORGAPRED selects CYTOQUBE® from Hamamatsu Photonics for personalized oncology research and therapeutic discovery

April 15, 2026

ORGAPRED, a France-based core facility specializing in Patient-Derived Tumor Organoid (PDTO) research, has selected the CYTOQUBE high-throughput 3D…

HHealth

Mother hug and consoling the little boy from nightmare

April 14, 2026

A novel framework reveals why nightmares persist in children, and how building confidence and coping skills could help…

HHealth

New adaptive finger brace could improve recovery for joint injuries

April 13, 2026

Scientists investigating the naturally occurring immunopeptide PEPITEM have shown reductions in arthritic joint swelling to a degree comparable…

HHealth

DNA origami vaccine platform shows promise against multiple infectious viruses

April 11, 2026

Breast cancer (BCA) is one of the most common cancers worldwide, with high mortality and morbidity in women.…

HHealth

Early B cell response prevents Oropouche virus from reaching the brain

April 1, 2026

Researchers at the National Institutes of Health (NIH) have identified a novel, highly potent opioid that shows potential…

HHealth

April 1, 2026

A simple fiber supplement could reshape the gut microbiome, stabilize blood sugar spikes, and even prevent preterm births…

HHealth

AI voice agents helped improve accuracy of blood pressure measurements in older adults

March 25, 2026

In a new Dartmouth Cancer Center (DCC) study led by clinical researcher Tyler J. Curiel, MD, MPH, FACP,…

HHealth

Study: Effects of hypocaloric wholegrain rye vs refined wheat diets on weight loss, cardiometabolic risk factors and gut microbiota: A 12-week randomized controlled trial. Image Credit: Sham Clicks / Shutterstock

March 25, 2026

A 12-week randomized trial found that wholegrain rye did not beat refined wheat for weight loss, but it…

TTechnology

Study: In vivo metabolic tagging and targeting of circulating red blood cells. Image Credit: The1969 Studio / Shutterstock

March 24, 2026

A new preclinical study shows that red blood cells can be tagged in vivo and used as long-lasting…

HHealth

Study: Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer

March 23, 2026

Despite hopes raised by earlier observational studies and biomarker shifts, The Lancet trials found that oral semaglutide did…

Targeting glutamine metabolism enhances CAR-macrophage cancer therapy

Dutch study shows off-label targeted therapies benefit more cancer patients

ORGAPRED selects CYTOQUBE® from Hamamatsu Photonics for personalized oncology research and therapeutic discovery

A new model to break the cycle of chronic nightmares in children

Natural peptide PEPITEM shows promise in reducing arthritic joint swelling

Nanomedicine offers targeted solutions for breast cancer treatment

Highly potent opioid shows potential as therapy for pain and opioid use disorder

Fiber supplement stabilizes blood sugar in gestational diabetes

Blood pressure drug boosts effectiveness of cancer therapy

Wholegrain rye changes gut bacteria and lowers inflammation in obesity trial

Scientists turn red blood cells into long-lasting drug and imaging carriers in mice

Oral semaglutide fails to slow early Alzheimer’s decline in two phase 3 trials